Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon
Szukaj Study Connect
  • NCT07412704

Not Yet Recruiting

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis - IM062-0001

Zaktualizowano: 20 luty, 2026   |   ClinicalTrials.gov

Wydruk podsumowania

BIERZESZ POD UWAGĘ TO BADANIE?
Wydrukuj tę stronę i przewodnik po badaniu, aby pomóc sobie w rozmowie z lekarzem.
Skorzystaj z Przewodnika po badaniu, aby dowiedzieć się o procesie badań klinicznych. Zapoznaj się z kluczowymi czynnikami, które należy wziąć pod uwagę przed podjęciem decyzji i zanotuj pytania, aby zadać je personelowi medycznemu.
Wydrukuj tę stronę IM062-0001
Pobierz przewodnik

WYBIERZ JĘZYK

Szczegóły badania

  • Phase 1/Phase 2

    Etap

  • Płeć

  • 18-65

    Zakres wieku

  • 17

    Lokalizacje

  • Not Yet Recruiting

Opcje leczenia

Grupy badania
PRZYPISANA INTERWENCJA
Experimental: Cohort A1
Drug: BMS-986528
Experimental: Cohort A2
Drug: BMS-986528
Experimental: Cohort A3
Drug: BMS-986528
Experimental: Cohort A4
Drug: BMS-986528
Experimental: Cohort A5
Drug: BMS-986528
Experimental: Cohort A6
Drug: BMS-986528
Experimental: Cohort A7
Drug: BMS-986528
Experimental: Cohort A8
Drug: BMS-986528
Experimental: Cohort B1
Drug: BMS-986528
Experimental: Cohort B2
Drug: BMS-986528

Kluczowe kryteria kwalifikacyjne

Inclusion Criteria - Adult participants with rheumatoid arthritis (RA) who meet definition of difficult-to-treat. Exclusion Criteria - Juvenile arthritis or onset of inflammatory arthritis before age 18. - Seronegative RA participants in whom polymyalgia rheumatica has not been ruled out. - Active fibromyalgia with pain symptoms or signs that would interfere with joint assessment. - Other protocol-defined Inclusion/Exclusion criteria apply.